MedServe, founded in 2017, is revolutionizing drug management in outpatient healthcare facilities. With its digital narcotic management system, MedServe uniquely addresses the critical issue of drug diversion, ensuring enhanced security, compliance, and efficiency.
Operating at the intersection of Health Care, Medical Devices, and Pharmaceutical industries, MedServe is headquartered in the United States. Its innovative approach is underscored by its slogan: "Your time & facility’s security are important - store & track controlled drugs with MedServe’s modern narcotic mgmt tech."
The company recently secured a Seed Round investment of $735.00K on 29 June 2023, reflecting confidence in its potential to address a pressing need in the healthcare sector. Though the names of the investors remain undisclosed, this funding marks a crucial milestone for MedServe's continued growth and market penetration.